HealthEquity, Inc. (NASDAQ:HQY) Position Boosted by Victory Capital Management Inc.

Victory Capital Management Inc. grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 68.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 413,732 shares of the company's stock after acquiring an additional 168,819 shares during the quarter. Victory Capital Management Inc. owned about 0.48% of HealthEquity worth $27,430,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC lifted its position in HealthEquity by 19.1% in the third quarter. FMR LLC now owns 5,648,992 shares of the company's stock worth $412,659,000 after buying an additional 907,743 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of HealthEquity by 58.2% during the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company's stock valued at $119,831,000 after buying an additional 664,979 shares during the last quarter. Invesco Ltd. lifted its stake in shares of HealthEquity by 164.6% during the 3rd quarter. Invesco Ltd. now owns 484,043 shares of the company's stock worth $35,359,000 after acquiring an additional 301,078 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in HealthEquity by 12.1% during the 3rd quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company's stock valued at $161,051,000 after acquiring an additional 238,116 shares during the period. Finally, Eagle Asset Management Inc. bought a new position in HealthEquity in the 3rd quarter valued at $15,581,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

HQY traded down $2.37 on Wednesday, reaching $78.01. The stock had a trading volume of 704,645 shares, compared to its average volume of 593,427. The business's 50-day moving average price is $80.66 and its two-hundred day moving average price is $74.72. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. HealthEquity, Inc. has a 12-month low of $53.15 and a 12-month high of $84.49. The company has a market cap of $6.69 billion, a P/E ratio of 121.89, a price-to-earnings-growth ratio of 1.28 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. Sell-side analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 2,499 shares of the company's stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now owns 49,996 shares of the company's stock, valued at approximately $3,999,680. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the business's stock in a transaction on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares of the company's stock, valued at $3,999,680. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. Insiders have sold a total of 71,322 shares of company stock valued at $5,682,895 in the last 90 days. 2.70% of the stock is owned by insiders.

Analyst Ratings Changes

HQY has been the subject of several research reports. JPMorgan Chase & Co. boosted their price objective on shares of HealthEquity from $86.00 to $108.00 and gave the company an "overweight" rating in a research report on Tuesday, April 2nd. JMP Securities started coverage on shares of HealthEquity in a research report on Thursday, April 4th. They set a "mkt outperform" rating and a $101.00 target price for the company. KeyCorp boosted their target price on HealthEquity from $85.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, March 22nd. Royal Bank of Canada upped their price target on shares of HealthEquity from $90.00 to $92.00 and gave the company an "outperform" rating in a research note on Wednesday, March 20th. Finally, Bank of America lifted their price target on HealthEquity from $93.00 to $97.00 and gave the stock a "buy" rating in a research report on Wednesday, March 20th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.